Computerized System for Staging Peritoneal Surface Malignancies

scientific article published on 12 November 2015

Computerized System for Staging Peritoneal Surface Malignancies is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1037203748
P356DOI10.1245/S10434-015-4966-5
P932PMC publication ID4819745
P698PubMed publication ID26564242
P5875ResearchGate publication ID283746013

P50authorDaniele BiacchiQ56816681
Simone SibioQ63379104
Paolo SammartinoQ67954757
P2093author name stringAngelo Di Giorgio
Fabio Accarpio
Tommaso Cornali
Alessio Impagnatiello
Bernard Luraschi
P2860cites workModified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal originQ57108862
Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancerQ79372207
Quantitative intra-operative assessment of peritoneal carcinomatosis - a comparison of three prognostic toolsQ83474834
Peritoneal cancer patients not suitable for cytoreductive surgery and HIPEC during explorative surgery: risk factors, treatment options, and prognosisQ85801157
Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancerQ24556616
Looking up: Recent advances in understanding and treating peritoneal carcinomatosisQ26849259
Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in JapanQ30719628
Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapyQ34276733
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trialQ34928467
Effects of neoadjuvant intraperitoneal/systemic chemotherapy (bidirectional chemotherapy) for the treatment of patients with peritoneal metastasis from gastric cancerQ36151519
Postoperative residual disease evaluation in the locoregional treatment of peritoneal surface malignancyQ37252011
Pharmacology of perioperative intraperitoneal and intravenous chemotherapy in patients with peritoneal surface malignancyQ38047542
The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal CarcinomatosisQ38214032
Morbidity of the abdominal wall resection and reconstruction after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC).Q38253190
Port-site metastases is an independent prognostic factor in patients with peritoneal carcinomatosis.Q38260594
Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French studyQ39928697
Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis.Q41146040
Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.Q42655076
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.Q43703526
Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).Q43722576
Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study.Q44408342
Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy?Q44522396
Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapyQ44911605
Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients.Q45341695
Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).Q45375023
Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastasesQ45868124
Number of residual nodules, better than size, defines optimal surgery in advanced epithelial ovarian cancerQ47407458
Patient selection for cytoreductive surgery in colorectal peritoneal carcinomatosis using serum tumor markers: an observational cohort study.Q50945368
Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent or progressive diffuse malignant peritoneal mesothelioma: clinicopathologic characteristics and survival outcome.Q51120959
A novel nomogram for peritoneal mesothelioma predicts survival.Q51288705
Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: A multi‐institutional studyQ53264117
Comparison between MRI and CT in prediction of peritoneal carcinomatosis index (PCI) in patients undergoing cytoreductive surgery in relation to the experience of the radiologist.Q53646381
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue5
P304page(s)1454-1460
P577publication date2015-11-12
P1433published inAnnals of Surgical OncologyQ2853069
P1476titleComputerized System for Staging Peritoneal Surface Malignancies
P478volume23